We have used reduced doses of Chinese herbs for estimation of urinary tract infections (UTIs) patients with stable impairment of renal function. A total of 33 adult female patients with moderately impaired renal function and symptomatic UTIs were included in this study. Urine cultures were carried out. Patients were monitored clinically and with various laboratory tests. Chinese herbal concoction divided by milligrams of creatinine per 100 ml were orally administrated for ten days. Three patients were excluded from final analysis. Most of the patients responded symptomatically to treatment. Chinese herbs eradicated the primary pathogen in 68.7% of the patients at the day 10 of treatment. Two patients relapsed (one had abbreviated courses of therapy) 6 to 8 days posttreatment. Organisms which recurred included Escherichia coli and Pseudomonas aeruginosa. Bacterial reinfections occurred 5 to 8 days posttreatment in four patients. Adverse reactions observed among the 30 patients were rare. Nausea (6.67%) and mild elevation of hepatic enzymes (3.33%) were probably drug related. Nausea disappeared when the therapy ended. Elevated hepatic enzymes resumed at the 2-week follow-up. Two patients demonstrated slight increases in serum creatinine on day 10 of treatment. One patient had a 12.5% elevation over baseline and the other had a 13.0% elevation. Serum creatinine values had improved in these two patients at 4-week follow-up. Chinese herbal medicine was effective and safe in the treatment of UTIs with renal insufficiency.
Introduction
Complicated urinary tract infections (UTIs) may occur in all age groups and are frequently associated with either structural or functional urinary tract abnormalities. Examples include foreign bodies such as calculi (stones), indwelling catheters or other drainage devices, obstruction, immunosuppression, and renal failure (Lichtenberger et al., 2008) . The management of UTIs in patients with chronic renal insufficiency has attracted little attention. An in-depth literature review identified only one publication that addressed the subject (Bennett and Craven, 1976 ). Many UTIs-controlled studies excluded patients with impaired renal function. UTIs in these patients seems not to be a problem that is sufficient to generate academic interest.
Herbal remedies are herbs, herbal materials, herbal preparations and finished herbal products, that contain as active ingredients parts of plants, or plant materials, or combinations thereof used to treat a multitude of ailments throughout the world (WHO, 2002) . In our previous study, some Chinese herbs were shown to be clinically effective and relatively free from toxic side effects when given orally to patients of UTIs caused by fluoroquinolone-resistant strains. The patients However, every drug is a potential poison. Thus some herbal remedies are toxic especially when used over a period. The maintenance dose for Chinese herbal drugs in continuous drug administration is inversely proportional to the half-life of the drug at reduced renal function. It is postulated that dividing the normal daily dosage by the patient's serum creatinine (in milligrams per 100 ml) will result in effective serum and urine concentrations in the treatment of UTIs and not cause an accumulation of drug in the patient's serum. In the present study, we have used reduced doses of these Chinese herbs for estimation of serious UTIs patients with stable impairment of renal function, based solely on pretreatment serum creatinine.
Materials and methods
Study protocol was approved by the First Affilliated Hospital to Changchun University of Chinese Medicine.
Protocol summaries were reviewed by the participants, and written, informed consent was obtained on the day of the study after a detailed explanation of the study purpose and methods. A total of 33 adult female patients with moderately impaired renal function (serum creatinine, 1.5 to 2.5 mg/100 ml) and symptomatic UTIs (2 with bacteremia) were included in this study from April 2008 to September 2009. The patients were generally older (36 to 75 years old; mean, 58 years) with significant underlying diseases. Among group, 21 had neurogenic bladders, vesicoureteral reflux, calculi, or obstructive lesions, 11 were diabetes, and 8 required intermittent or indwelling urinary catheters; and 25 required hospitalization for their infections or were hospitalized for other physical illnesses when treatment was initiated.
The diagnosis of UTIs was based on the presence of signs and symptoms suggestive of UTIs, the presence of pyuria and bacteriuria. Urine cultures with colony counts ≥10 5 CFU were carried out on midstream clean-catch specimens before treatment. The urine cultures were repeated at 5 days, 10 days, and 1 week after the treatment. All urine samples were plated initially on blood agar plates and were quantitated by pour plates or calibrated wire loops. Cultures were observed for growth for 48 hrs. All bacterial isolates were identified by standard procedures (Edwards and Ewing,1955 ).
Patients were monitored clinically and with various laboratory tests to determine the incidences of adverse reactions. Blood urea nitrogen, serum creatinine, creatinine clearance, hemoglobin, hematocrit, total leukocyte count with differential count, alkaline phosphatase, lactate dehydrogenase, serum glutamic oxaloacetic transaminase, and serum bilirubin were determined in all patients before and after the study. The criterion for nephrotoxicity was a 20% elevation in creatinine over baseline.
All the patients were orally administrated Chinese herbal concoction. The prescription was as follow: Tong Cao . After cooling, the concoction was stored at 18-24 0 C, humidity 55%-70%. The concoction was orally administrated at 200ml/day divided by milligrams of creatinine per 100 ml for ten days.
The therapeutic results were assessed according to the urine cultures. The following standards were used: cure, negative culture at 1 week after treatment; persistence, ≥10 5 colonies of the original organism per ml during treatment;
relapse, negative culture during therapy and ≥10 5 colonies of the original organism per ml at follow-up; reinfection, ≥10 Most of the patients responded symptomatically to treatment. Bacteriologic outcomes are shown in Table 1 . Adverse reactions observed among the 30 patients were rare. Nausea (6.67%) and mild elevation of hepatic enzymes (3.33%) were probably drug related. Nausea disapeared when the therapy ended. Elevated hepatic enzymes resumed at the 2-week follow-up. Complaints of nervousness, blurred vision, and aching arms were not associated with objective findings and were of equivocal significance.
Two patients demonstrated slight increases in serum creatinine on day 10 of treatment. No. 1 patient had a 12.5% elevation over baseline and no. 2 had a 13.0% elevation ( Table 2 ). Increased renal impairment was attributed to possible nephrotoxic reaction to herbal remedy. The changes in serum creatinine and blood urea nitrogen are depicted in Table 2 . One patient (no. 2 in Table 2 ) received small doses of diuretics. Dialysis was not attempted due to the general clinical condition and the underlying malignant disease of the patients. Serum creatinine values had improved in these two patients at 4-week follow-up.
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Discussion
In UTIs, the clearance is abnormal in about half of the cases on the affected side. Contralateral compensation and intrarenal compensation mechanisms tend to occur. In addition to these compensation mechanisms, hyperfiltration is present in many cases of UTIs with intact or unilaterally damaged kidneys (Francisca et al., 1999) . So the management of UTIs in patients with renal insufficiency is crucial to prevent renal function deterioration. Some Chinese herbs in the study have been The safety of herbal remedy determines the well being of the patient taking the medication. Oral Chinese herbal concoction is well tolerated. Nausea and mild elevation of hepatic enzymes were observed. These adverse reactions disappeared after discontinuation of the medication. Although we could not exclude Chinese herbs as a contributory factor, these events were probably caused by unrelated underlying problems.
The renal function profile is a major concern in drug therapy. As observed by us, the nephrotoxic reaction to these Chinese herbs is reversible, which is probably due to applying the formula for dose adjustment proposed here. Further studies with larger populations are needed to show if the low nephrotoxic potential accounted for can be reproduced.
In short, the management of UTIs in patients with renal insufficiency requires reduction of dosage to avoid high serum concentrations and the concomitant increased risk for concentration-dependent adverse drug events. The appropriate duration of Chinese herbal therapy in patients with renal insufficiency is unknown. Duration studies are needed in the future.
The design of our study has some shortcomings. A randomized-controlled double-blind trial would have been ideal but was not deemed feasible in this study given the oral route of administration for Chinese herbal concoction. Obviously this initial limited therapeutic trial must be extended to a larger group of patients and include long-term follow-up evaluations before a definite conclusion can be drawn.
In spite of these limitations, we considered Chinese herbs to be effective and safe in the treatment of UTIs with stable impairment of renal function. Increases in dosage intervals or shorter periods of treatment should theoretically result in less toxicity, but probably also reduce effectiveness. Prospective studies comparing dosage regimens with regard to these factors are required.
